Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis

গ্রন্থ-পঞ্জীর বিবরন
Parent link:Molecules
Vol. 26, iss. 21.— 2021.— [6583, 22 p.]
সংস্থা লেখক: Национальный исследовательский Томский политехнический университет Инженерная школа новых производственных технологий Научно-образовательный центр Н. М. Кижнера
অন্যান্য লেখক: Crocetti L. Letizia, Vergelli C. Claudia, Guerrini G. Gabriella, Giovannoni M. P. Maria Paola, Kirpotina L. N. Liliya Nikolaevna, Khlebnikov A. I. Andrey Ivanovich, Ghelardini C. Carla, Mannelli Lorenzo Di Cesare, Lucarini E. Elena, Shchepyotkin I. A. Igor Aleksandrovich, Quinn M. T. Mark
সংক্ষিপ্ত:Title screen
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint inflammation, cartilage damage and bone destruction. Although the pharmacological treatment of RA has evolved over the last few years, the new drugs have serious side effects and are very expensive. Thus, the research has been directed in recent years towards new possible targets. Among these targets, N-formyl peptide receptors (FPRs) are of particular interest. Recently, the mixed FPR1/FPR2 agonist Cpd43, the FPR2 agonist AT-01-KG, and the pyridine derivative AMC3 have been shown to be effective in RA animal models. As an extension of this research, we report here a new series of pyridinone derivatives containing the (substituted)phenyl acetamide chain, which was found to be essential for activity, but with different substitutions at position 5 of the scaffold. The biological results were also supported by molecular modeling studies and additional pharmacological tests on AMC3 have been performed in a rat model of RA, by repeating the treatments of the animals with 10 mg/kg/day of compound by 1 week.
প্রকাশিত: 2021
বিষয়গুলি:
অনলাইন ব্যবহার করুন:https://doi.org/10.3390/molecules26216583
বিন্যাস: বৈদ্যুতিক গ্রন্থের অধ্যায়
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=667752

MARC

LEADER 00000naa0a2200000 4500
001 667752
005 20250404154519.0
035 |a (RuTPU)RU\TPU\network\38963 
035 |a RU\TPU\network\38952 
090 |a 667752 
100 |a 20220419d2021 k||y0rusy50 ba 
101 0 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis  |f L. Crocetti, C. Vergelli, G. Guerrini [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 35 tit.] 
330 |a Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint inflammation, cartilage damage and bone destruction. Although the pharmacological treatment of RA has evolved over the last few years, the new drugs have serious side effects and are very expensive. Thus, the research has been directed in recent years towards new possible targets. Among these targets, N-formyl peptide receptors (FPRs) are of particular interest. Recently, the mixed FPR1/FPR2 agonist Cpd43, the FPR2 agonist AT-01-KG, and the pyridine derivative AMC3 have been shown to be effective in RA animal models. As an extension of this research, we report here a new series of pyridinone derivatives containing the (substituted)phenyl acetamide chain, which was found to be essential for activity, but with different substitutions at position 5 of the scaffold. The biological results were also supported by molecular modeling studies and additional pharmacological tests on AMC3 have been performed in a rat model of RA, by repeating the treatments of the animals with 10 mg/kg/day of compound by 1 week. 
461 |t Molecules 
463 |t Vol. 26, iss. 21  |v [6583, 22 p.]  |d 2021 
610 1 |a труды учёных ТПУ 
610 1 |a электронный ресурс 
610 1 |a pyridinone 
610 1 |a formyl peptide receptors 
610 1 |a agonists 
610 1 |a rheumatoid arthritis 
610 1 |a molecular docking 
610 1 |a агонисты 
610 1 |a ревматоидный артрит 
610 1 |a лечение 
610 1 |a хронические заболевания 
701 1 |a Crocetti  |b L.  |g Letizia 
701 1 |a Vergelli  |b C.  |g Claudia 
701 1 |a Guerrini  |b G.  |g Gabriella 
701 1 |a Giovannoni  |b M. P.  |g Maria Paola 
701 1 |a Kirpotina  |b L. N.  |g Liliya Nikolaevna 
701 1 |a Khlebnikov  |b A. I.  |c Chemist  |c Professor of Tomsk Polytechnic University  |f 1963-  |g Andrey Ivanovich  |3 (RuTPU)RU\TPU\pers\33927  |9 17500 
701 1 |a Ghelardini  |b C.  |g Carla 
701 0 |a Mannelli Lorenzo Di Cesare 
701 1 |a Lucarini  |b E.  |g Elena 
701 1 |a Shchepyotkin  |b I. A.  |g Igor Aleksandrovich 
701 1 |a Quinn  |b M. T.  |g Mark 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Инженерная школа новых производственных технологий  |b Научно-образовательный центр Н. М. Кижнера  |3 (RuTPU)RU\TPU\col\23556 
801 0 |a RU  |b 63413507  |c 20220419  |g RCR 
856 4 |u https://doi.org/10.3390/molecules26216583 
942 |c CF